We also analyzed the differentially expressed TFs between four subtypes of BC (luminal A, luminal B, HER-2 enriched, and triple negative breast cancer) and normal breast samples (Figures 2B, C). This evidence concerns the gene ERBB2 and triple-negative breast carcinoma.